ProQR Therapeutics NV (PRQR)
1.405
-0.06
(-4.42%)
USD |
NASDAQ |
Jun 10, 16:00
1.405
0.00 (0.00%)
After-Hours: 17:50
ProQR Therapeutics 1 Year Total Returns (Daily) : -19.67% for June 9, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| June 09, 2026 | -19.67% |
| June 08, 2026 | -19.90% |
| June 05, 2026 | -16.20% |
| June 04, 2026 | -15.47% |
| June 03, 2026 | -17.42% |
| June 02, 2026 | -17.42% |
| June 01, 2026 | -14.46% |
| May 29, 2026 | -9.20% |
| May 28, 2026 | -7.65% |
| May 27, 2026 | -8.24% |
| May 26, 2026 | -5.99% |
| May 22, 2026 | -7.69% |
| May 21, 2026 | -16.28% |
| May 20, 2026 | -18.75% |
| May 19, 2026 | -16.37% |
| May 18, 2026 | -6.79% |
| May 15, 2026 | -2.45% |
| May 14, 2026 | 6.45% |
| May 13, 2026 | 11.11% |
| May 12, 2026 | 0.63% |
| May 11, 2026 | 0.00% |
| May 08, 2026 | 1.94% |
| May 07, 2026 | 0.64% |
| May 06, 2026 | 10.26% |
| May 05, 2026 | -9.44% |
| Date | Value |
|---|---|
| May 04, 2026 | -17.59% |
| May 01, 2026 | -9.88% |
| April 30, 2026 | -5.42% |
| April 29, 2026 | -5.52% |
| April 28, 2026 | -3.90% |
| April 27, 2026 | 4.20% |
| April 24, 2026 | 0.65% |
| April 23, 2026 | 12.41% |
| April 22, 2026 | 29.63% |
| April 21, 2026 | 31.44% |
| April 20, 2026 | 61.40% |
| April 17, 2026 | 74.56% |
| April 16, 2026 | 71.05% |
| April 15, 2026 | 67.23% |
| April 14, 2026 | 68.64% |
| April 13, 2026 | 60.71% |
| April 10, 2026 | 63.72% |
| April 09, 2026 | 65.00% |
| April 08, 2026 | 61.95% |
| April 07, 2026 | 45.30% |
| April 06, 2026 | 53.39% |
| April 02, 2026 | 24.82% |
| April 01, 2026 | 32.56% |
| March 31, 2026 | 21.80% |
| March 30, 2026 | 7.86% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Pharming Group NV | 5.37% |
| NewAmsterdam Pharma Co. NV | 50.69% |
| Kamada Ltd. | 7.04% |
| Syndax Pharmaceuticals, Inc. | 59.51% |
| Opus Genetics, Inc. | 288.6% |